The Numbers at a Glance
Industry estimates vary because definitions differ — some include wellness and dental tourism, some do not, and some include cross-border EU care under the EU Directive. Treat all figures as order-of-magnitude.
Global Market Size and Growth
Industry estimates from Patients Beyond Borders, Grand View Research, Allied Market Research, Fortune Business Insights and the Medical Tourism Association place the global medical tourism market in the range of US $100–200 billion annually as of the mid-2020s, with projected compound annual growth rates of 12–25% depending on the source and scope definition.
Growth drivers consistently cited:
- Healthcare cost inflation in the US private system.
- Public health system waiting times in the UK (NHS), Ireland (HSE), Canada (provincial plans), Australia and New Zealand.
- Restricted scope of elective cover under national systems and employer-sponsored plans.
- Expanded hospital accreditation (JCI, ISO) in destination countries.
- Digital platforms lowering the coordination cost of international treatment.
Top Destinations by International Patient Volume
| Rank | Destination | Specialty dominance | Primary source markets |
|---|---|---|---|
| 1 | Mexico | Bariatric, dental, cosmetic, orthopedic | US, Canada |
| 2 | Turkey | Hair transplants, dental, cosmetic, bariatric | UK, Germany, Middle East, EU |
| 3 | Thailand | Cosmetic, gender-affirming, orthopedic, cardiac | Australia, UK, Middle East, US |
| 4 | India | Cardiac, oncology, orthopedic, complex tertiary | Africa, Middle East, Bangladesh, UK |
| 5 | Costa Rica | Dental, cosmetic | US, Canada |
| 6 | Colombia | Aesthetic plastic surgery, dental | US, Caribbean, EU |
| 7 | South Korea | Cosmetic, dermatology | China, Japan, Southeast Asia, US |
| 8 | Malaysia | Cardiac, orthopedic, oncology | Indonesia, Australia, UK |
| 9 | Singapore | Complex tertiary, premium cardiac, oncology | Indonesia, Southeast Asia, Middle East |
| 10 | Hungary | Dental, fertility | UK, Ireland, Germany, Austria |
| 11 | Poland | Dental, cosmetic | UK, Germany, Scandinavia |
| 12 | Brazil | Aesthetic plastic surgery | Latin America, US, EU |
| 13 | Dominican Republic | Cosmetic surgery | US, Caribbean |
| 14 | Panama | Premium cardiac, orthopedic, dental | US, Central America |
| 15 | Spain | IVF (egg donation), cosmetic | UK, Ireland, France, Germany |
Most Common Procedures
| Procedure category | Typical leading destinations |
|---|---|
| Dental implants, All-on-4/6, crowns, veneers | Turkey, Mexico, Hungary, Costa Rica, Poland |
| Bariatric surgery (gastric sleeve, bypass) | Mexico, Turkey, India, Thailand |
| Cosmetic surgery (rhinoplasty, breast, facelift, lipo, tummy tuck) | Turkey, Colombia, Mexico, Thailand, South Korea, Dominican Republic |
| Hair transplants (FUE, DHI, Sapphire) | Turkey, Mexico |
| Brazilian Butt Lift / gluteal fat grafting | Colombia, Mexico, Turkey, Dominican Republic, Brazil |
| IVF / fertility treatment | Spain, Czech Republic, Greece, Hungary, Mexico |
| Cardiac surgery (CABG, valve, angioplasty) | India, Thailand, Malaysia, Singapore, Panama |
| Orthopedic (hip/knee replacement, spine) | India, Thailand, Mexico, Costa Rica, Malaysia |
| LASIK / ophthalmic | Turkey, Mexico, India, South Korea |
| Gender-affirming surgery | Thailand |
Cost Comparison by Procedure
Approximate destination cost ranges as a percentage of US private pricing (US = 100%). Orientation only; actual quotes vary significantly by surgeon and facility.
| Procedure | Mexico | Turkey | Thailand | India | Colombia |
|---|---|---|---|---|---|
| Gastric sleeve | 20–30% | 20–35% | 35–50% | 15–30% | 25–40% |
| Dental implant (single) | 15–25% | 10–25% | 20–35% | 15–25% | 20–35% |
| Hair transplant (full FUE) | 20–35% | 8–20% | 25–40% | 15–30% | 25–40% |
| Hip replacement | 30–45% | 30–50% | 30–50% | 15–25% | 30–45% |
| Coronary bypass (CABG) | 25–40% | 30–50% | 25–45% | 10–20% | 25–45% |
| IVF cycle | 40–60% | 30–50% | 40–60% | 25–45% | 40–60% |
| BBL / fat grafting | 25–40% | 15–30% | 30–50% | 20–35% | 20–35% |
Source Markets: Where Patients Come From
- United States: largest single outbound market by volume. Primary destinations: Mexico, Costa Rica, Colombia, Dominican Republic, Thailand, Turkey.
- United Kingdom & Ireland: strong outflow to Turkey (dental, hair, cosmetic), Hungary and Poland (dental), Spain (IVF).
- Canada: primary flow to Mexico and the US for wait-time-driven procedures; Costa Rica, Colombia for cosmetic; Turkey for dental and hair.
- Germany, France, Italy, Netherlands, Scandinavia: significant flows to Turkey, Hungary, Poland, Czech Republic, and Spain under the EU Cross-Border Healthcare Directive.
- Australia & New Zealand: Thailand is the dominant destination, with Malaysia and India growing.
- Middle East: Turkey, Germany, Thailand, India, and increasingly South Korea.
- Sub-Saharan Africa: India dominates, with growing flows to Turkey and the UAE.
The Insurance Gap
One of the most consistent findings across industry reports, regulator warnings (UK FCDO, US CDC, Australian DFAT) and published complication literature is that most medical tourists are uninsured for the complication risk. Specifically:
- Standard travel insurance policies exclude elective surgery and its complications.
- National health plans do not fund elective care abroad or routine follow-up of it.
- Private medical insurance products almost universally exclude elective procedures abroad.
- Clinic “complication warranties” typically only cover re-treatment at that specific clinic within a limited window.
This has created a distinct insurance category — medical travel complication insurance — purpose-built to cover complications of a planned procedure abroad, including a post-procedure window that continues after the patient returns home.
If you are part of the 14–16 million patients travelling abroad for a procedure, put medical travel complication insurance in place before you book your flights.
Get Your Personalised Quote Ask AvaComplications & Safety
Published complication rates for routine medical-tourism procedures at top-tier accredited facilities are broadly comparable to domestic private care. The material difference for medical tourists is not necessarily a higher raw complication rate but the logistical challenge of managing a complication abroad or after returning home. Specific flags from surgical-society literature:
- Brazilian Butt Lift (BBL) remains the highest-mortality cosmetic procedure in routine practice, driven by fat-embolism risk. International societies (ISAPS, ASPS, ASERF, BAAPS) have published specific safety guidelines.
- Bariatric staple-line leak is the most serious early bariatric complication and typically presents within 1–2 weeks.
- Pulmonary embolism and DVT are elevated in post-surgical patients taking long-haul flights home.
- Hair-transplant technician mills have been publicly flagged by the ISHRS, and “Turkey teeth” (aggressive crown preparation on healthy teeth) by the British Dental Association, GDC and other national dental bodies.
Frequently Asked Questions
How big is the global medical tourism market?
Credible industry estimates place it in the US $100–200 billion range annually, growing 12–25% per year depending on methodology.
How many people travel abroad for surgery each year?
Roughly 14–16 million patients cross borders for medical treatment annually.
What are the top medical tourism destinations?
Mexico, Turkey, Thailand, India, Costa Rica, Colombia, South Korea, Malaysia, Singapore, Hungary, Poland — each with distinct specialty profiles.
How much do patients save on medical tourism?
Typically 40–90% vs US private pricing for equivalent procedures, varying by destination and complexity.
How often do complications happen in medical tourism?
At top-tier accredited facilities, complication rates are broadly comparable to domestic private care. The larger issue is logistical — managing a complication after returning home.
Sources and methodology notes
- Patients Beyond Borders industry estimates.
- Grand View Research, Allied Market Research, Fortune Business Insights market-size reports.
- Medical Tourism Association industry data.
- Joint Commission International (JCI) accredited facility lists.
- EU Cross-Border Healthcare Directive (2011/24/EU) reporting.
- UK FCDO, US CDC and Australian DFAT public-health advisories on medical tourism.
- Published complication literature from ISAPS, ASPS, ASERF, BAAPS, ISHRS, ASMBS, IFSO.
Figures are harmonised from public industry reporting as of Q2 2026. This page is updated periodically as new data is published.
Citing this page? Please link to https://aviaprotect.com/medical-tourism-statistics-2026. Journalists and researchers are welcome to use these figures with attribution.
This article is for informational purposes only and does not constitute insurance, medical, or financial advice. Coverage terms of medical travel complication insurance are subject to the policy certificate issued by the underwriter. Avia provides insurance brokerage services only.
Related reading: Medical Tourism Risks · JCI Accreditation Explained · Best Countries for Surgery Abroad · Is Medical Tourism Safe? · Medical Travel Insurance (Full Guide)